Will Shapiro, vice president of data science at Flatiron Health, discusses opportunities to implement artificial intelligence in cancer care.
There is a huge opportunity for artificial intelligence (AI) and machine learning to revolutionize oncology care, says Will Shapiro, vice president of data science at Flatiron Health.
These findings were presented at the Association of Cancer Care Center's 50th Annual Meeting & Cancer Center Business Summit (ACCC AMCCBS).
Transcript
Can you elaborate on your AMCCBS presentation about building language models and their impact on cancer care?
I kind of want to give an overview of a lot of the terms that I think get thrown around pretty liberally these days—deep learning, natural language processing, artificial intelligence, and machine learning—to talk about how they relate to each other and give people a bit of a grounding on what they actually mean, because there's so much hype, especially around generative AI and artificial intelligence. I wanted to try to give people an intuitive understanding of what some of those terms mean. And then also, where the opportunity is for artificial intelligence and machine learning to truly revolutionize oncology and cancer care, which is something I'm incredibly excited about.
What specific aspects of AI or business intelligence (BI) did your presentation cover?
At Flatiron I kind of work across both [AI and BI]. My team comprises product data science, data reporting, business intelligence, workflow, automation, machine learning, and artificial intelligence. But [at AMCCBS], I really focused more on machine learning in artificial intelligence, in particular, and applications in oncology. One of the grounding things that I started with is the fact that 1 in 10 doctors are already using ChatGPT in their practice, and that's a significant fraction.
So, I think, just kind of understanding a bit more about how GPT works. I kind of broke down the acronym GPT, which is something that a lot of people don't necessarily know about, so just talked about how “G” is for generative and what is generative AI. It's something that people actually use every day without really even thinking about it. Autocomplete is an example of generative AI. And then pretrained models is what the “P” stands for. Pretrained models are really exciting, because they can do a lot of different things. They can answer a question, they can flag content that might be problematic, and they can write the next Harry Potter novel.
And then of course, they can also be used for things in oncology. I think one of the big appeals of this new generation of models is they can do so many different things. But with that generality comes tradeoffs, too. My team has found that often purpose-built models that just do one task, like read through a chart and figure out whether a patient has metastatic disease or not, often outperform these general pretrained models. So, that’s one of the things that I touched on. And then finally just to wrap it up, the “T” in GPT is the transformer architecture, which is something that was developed at Google in 2017, and I talked a bit about the transformer architecture.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More